Paul Cathcart

Paul is a consultant urological surgeon at Guy's Hospital having been head-hunted from University College Hospital London. Paul specialises in the management of prostate cancer and is one of the highest volume robotic prostate cancer surgeons in the UK performing over 100 robotic prostate cancer surgeries each year. Paul's particular clinical focus includes nerve-sparing robotic radical prostatectomy, radical prostatectomy for high-risk prostate cancer and salvage-robotic radical prostatectomy – robotic prostate removal for recurrent cancer.

Paul is the clinical co-ordinator for the National Prostate Cancer Audit and the chief investigator in a number of clinical trials including the PRIME study 'a study assessing intraoperative PET imaging during robotic prostate cancer surgery, the RAFT study' a trial assessing the efficacy and safety of salvage robotic prostate cancer surgery after focal therapy as well as the PROVENT study 'a trial assessing the efficacy of Vitamin D and aspirin to prevent prostate cancer progression in men on active surveillance for low risk prostate cancer'.